Business
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of
About this update from Brightspring Health Services, Inc.
[{"type":"text","content":"LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2025, increased Revenue guidance, and reiterated Adjusted EBITDA1 guidance. Financial Highlights(note: all figures represent continuing operations and exclude the Community Living business) Revenues of $3,334 million, up 28.2% compared to $2,601 million in the third quarter of 2024.Gross Profit of $392 million, up 21.3% compared to $323 million in the third quarter of 2024.Third quarter net income of $37.5 million, compared to net loss of $25.7 million in the third quarter of 2024.Adjusted EBITDA1 of $160 million, up 37.2% compared to $117 million in the third quarter of 2024.Planned divestiture of Community Living business to Sevita, announced on January 20, 2025, is expected to close in Q1 2026.Kohlberg Kravis Roberts & Co, L.P. and certain members of management, offered for sale in a secondary offering an aggregate of 15,000,000 shares of common stock of BrightSpring, of which BrightSpring repurchased 1,500,000 shares. Both the offering and share repurchase closed on October 22, 2025.Leverage was 3.31x, as calculated under our First Lien Credit Agreement at September 30, 2025. The results of the Community Living business are included in such calculation pursuant to our First Lien Credit Agreement.Increased 2025 Revenue guidance and reiterated Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions. All growth rates are shown as compared to the full year 2024 Revenue and Adjusted EBITDA results, excluding the Community Living business: Revenues of $12,500 million to $12,800 million, or 24.1% to 27.1% growth. Pharmacy Segment Revenue of $11,050 million to $11,300 million, or 26.2% to 29.1% growth.Provider Segment Revenue of $1,450 million to $1,500 million, or 10.0% to 13.8% growth. Adjusted EBITDA2 of $605 million to $615 million, or 31.5% to 33.7% growth. \"We are pleased with our third quarter organizational results,\" said Jon Rousseau, Chairman, President, and Chief Executive Officer of the Company. \"The performance in the quarter and ongoing progress throughout t...